ĀÜĄņĀŅĀ×

Caryn Peterson has served in a variety of leadership roles in the pharmaceutical and biotech fields, focusing on the development, integration, and implementation of global clinical and regulatory strategy across a broad range of therapeutic areas, including her current position as Executive Vice President, Regulatory Affairs of Gossamer Bio. Prior to joining Gossamer in 2018, Caryn was Managing Partner of Development & Strategic Consulting (ā€œDSCā€) Associates, LLC, Vice President, Regulatory Affairs at Syndax Pharmaceuticals, Inc., Vice President of Regulatory Affairs at FeRx Incorporated, and held managerial positions in both pharmaceutical development and regulatory affairs at Amylin Pharmaceuticals. Caryn began her career as a staff scientist at Hybritech Incorporated. She has coauthored several research publications and is a co-inventor on multiple patent applications.